Greg Mattingly, MD, and W. Clay Jackson, MD, DipTh, discuss a multidisciplinary approach to the evaluation and treatment of patients with tardive dyskinesia.
In this episode, Greg Mattingly, MD, and W. Clay Jackson, MD, DipTh, discuss who PCPs should screen for TD, adverse effects PCPs should put on their radar screen when monitoring patients on antipsychotics, how TD is different from parkinsonism, the use of anticholinergics, and which patients have an increased risk for TD when on antipsychotics.
Presenters:
Greg Mattingly, MD
Associate Clinical Professor
Psychiatry, Psychopharmacology
Washington University School of Medicine
St Louis, Missouri
President
St Charles Psychiatry Associates
St Charles, Missouri
W. Clay Jackson, MD, DipTh
Assistant Professor of Clinical Family Medicine & Psychiatry
College of Medicine
University of Tennessee
Director
Palliative Care
West Cancer Center
Memphis, Tennessee
Link to full program:
https://bit.ly/2RM8hfM